Favorskii rearrangement of 23-oxo-3-epi-smilagenin acetate induced by iodosobenzene

Tetrahedron Letters

Volumn 46, Issue 40, 2005, Pages 6897-6899

  Iglesias Arteaga, Martín A ^a   Velázquez Huerta, Gustavo A ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

23 Oxosapogenin; F ring contraction; Favorskii rearrangement

Indexed keywords

23 OXO 3 EPI SMILAGENIN ACETATE; 3 ALPHA ACETOXY 5 BETA SPIROSTAN 23 ONE; ACETIC ACID DERIVATIVE; DIACETOXYIODOBENZENE; IODOSOBENZENE; SPIROSTAN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; FAVORSKII REARRANGEMENT; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 27744553024     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2005.08.019     Document Type: Article

References (39)

1. Fieser, L.; Fieser, M. Steroids; Reinhold: San Francisco, 1959, and references therein.
2. For different steroid drugs see (a) Rosenkranz, G.; Mancera, O.; Sondheimer, F.; Djerassi, C. J. Org. Chem. 1956, 21, 520-522;
3. (b) Ringold, H. J.; Rosenkranz, G.; Sondheimer, F. J. Am. Chem. Soc. 1956, 78, 820-825;
4. (c) Rosenkranz, G.; Pataki, J.; Djerassi, C. J. Am. Chem. Soc. 1951, 73, 4055-4056;
5. For synthesis of ecdysone see (d) Lee E.; Liu, Y.-T.; Solomon, P. H.; Nakanishi, K. J. Am. Chem. Soc. 1976, 98, 1634-1635;
6. For synthesis of brassinosteroids analogs see (e) Iglesias-Arteaga, M. A.; Pérez, R.; Pérez, C. S.; Coll, F. Steroids 2002, 67, 159-163, and references therein.
7. For selected references on the synthesis of cephalostatins see (f) Kim, S.; Sutton, S. C.; Guo, C.; LaCour, T. G.; Fuchs, P. L. J. Am. Chem. Soc. 1999, 121, 2056-2070;
8. (g) Li, W.; LaCour, T. G.; Fuchs, P. L. J. Am. Chem. Soc. 2002, 124, 4548-4549;
9. (h) Betancor, C.; Freire, R.; Perez-Martin, I; Prange, T.; Suarez, E. Org. Lett. 2002, 4, 1295-1297;
10. (i) Lee, J. S.; Fuchs, P. L. Org. Lett. 2003, 5, 2247-2250.
11. (a) Hernández, R.; Marrero-Tellado, J. J.; Prout, K.; Suárez, E. J. Chem. Soc., Chem. Commun. 1992, 275-277;
12. (b) Sandoval-Ramirez, J.; Castro-Mendez, A.; Meza-Reyes, S.; Reyes-Vázquez, S.; Santillán, R.; Farfán, N. Tetrahedron Lett. 1999, 40, 5143-5146;
13. (c) LaCour, T. G.; Tong, Z.; Fuchs, P. L. Org. Lett. 1999, 1, 1815-1818;
14. (d) Morzycki, J. W.; Jastrzebska, I. Tetrahedron Lett. 2001, 42, 5989-5991;
15. (e) Anulewicz-Ostrowska, R.; Morzycki, J. W.; Jastrzebska, I; Wojcik, J. J. Org. Chem. 2002, 67, 6916-6924;
16. (f) Betancour, C.; Dorta, R. L.; Freire, R.; Martin, A.; Prange, T.; Suárez, E. J. Org. Chem. 1998, 63, 6355-6362;
17. (g) Sandoval-Ramírez, J.; Meza-Reyes, S.; del Río, R. E.; Hernandez-Linares, G.; Suárez-Rojas, A.; Rincón, S.; Farfán, N.; Santillán, R. L. Steroids 2003, 68, 199-204;
18. (h) Iglesias-Arteaga, M. A.; Sandoval-Ramírez, J.; Mata-Esma, M. Y.; Viñas-Bravo, O.; Bernès, S. Tetrahedron Lett. 2004, 45, 4921-4926;
19. (i) Jastrzebska, L; Morzycki, J. W.; Trochimowicz, U. Tetrahedron Lett. 2004, 45, 1929-1932;
20. (j) Cyranski, M. K.; Frelek, J.; Jastrzebska, I; Morzycki, J. W. Steroids 2004, 69, 395-400;
21. (k) Iglesias-Arteaga, M. A.; Velazquez-Huerta, G. A.; Méndez-Stivalet, J. M.; Galano, G.; Alvarez-Idaboy, J. R. Arkivoc 2005, vi, 109-126.
22. For reviews see (a) Moriarty, R. M.; Prakash, O. Acc. Chem. Res. 1986, 19, 244-250;
23. (b) Prakash, O.; Singh, P. S. Aldrichim. Acta 1994, 27, 15-23;
24. (c) Varvoglis, A. Tetrahedron 1997, 53, 1179-1255;
25. (d) Moriarty, R. M. J. Org. Chem. 2005, 70, 2893-2903;
26. For different applications of diacetoxyiodobenzene see (e) Conceptión, J. I; Francisco, C. G.; Freire, R.; Hernández, R.; Salazar, J. A.; Suárez, E. J. Org. Chem. 1986, 51, 402-404;
27. (f) Francisco, C. G.; Freire, R.; Rodríguez, M. S.; Suárez, E. Tetrahedron Lett. 1995, 36, 2141-2144;
28. (g) Boto, A.; Hernández, R.; Suárez, E. Tetrahedron Lett. 1999, 40, 5945-5948;
29. (h) Lee, S.; Fuchs, P. L. Org. Lett. 2002, 4, 317-318;
30. (i) Boto, A.; Hernández, R.; Suárez, E. J. Org. Chem. 2000, 65, 4930-4937;
31. (j) Iglesias-Arteaga, M. A.; Avila-Ortíz, C. G.; Juaristi, E. Tetrahedron Lett. 2002, 43, 5297-5300;
32. (k) Iglesias-Arteaga, M. A.; Castellanos, E.; Juaristi, E. Tetrahedron: Asymmetry 2003, 14, 577-580.
33. (a) Moriarty, R. M.; John, L. S.; Du, P. C. J. Chem. Soc., Chem. Commun. 1981, 641-642;
34. (b) Turuta, A. M.; Kamernitzky, A. V.; Fadeeva, T. M.; Zhulin, A. V. Synthesis 1985, 1129-1131;
35. (c) Daum, S. J. Tetrahedron Lett. 1984, 25, 4725-4728;
36. (d) Moriarty, R. M.; Prakash, I. Tetrahedron Lett. 1984, 25, 5867-5870.
37. 4, and evaporated. Chromatographic purification in silica gel (20 g) (hexane-ethyl acetate, 100/0 to 80/20 as eluent) afforded the rearranged compound 2 preceded by a small amount of the hydrolyzed 23-oxosapogenin.
38. (a) Agrawal, P. K.; Jain, D. C.; Gupta, R. K.; Thakur, R. S. Phytochemistry 1985, 24, 2479-2496;
39. (b) Iglesias-Arteaga, M. A.; Pérez Gil, R.; Pérez Martínez, C. S.; Coll Manchado, F. J. Chem. Res. (S) 1999, 48-49.